Skip to Main Content

Paper Details

The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.
Cancer Med
12
2023
Author NameAffiliation
Nadeem MoghalPrincess Margaret Cancer Centre, University Health Network
Ming-Sound TsaoPrincess Margaret Cancer Centre, University Health Network
Ming-Sound TsaoUniversity of Toronto
  • 1 - 3

Datasets

Release 1.2